StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

FENCBullishAnalyst Target Updateanalyst
Medium materiality6/10

Fennec Pharmaceuticals price target raised to $19

Nov 16, 2026, 9:04 AM EST1 sourcesAI-analyzed
Why it may matterVerify against the original reporting

Bullish analyst view, though the large implied upside is based on a single firm's target.

AI summary

What happened, with direct paths to the underlying reporting

B. Riley raised its FENC price target to $19 from an indicated share price of $11.62, implying about 63% upside to the target. This is an analyst estimate, not a forecast guarantee.

  • B. Riley raised its FENC target to $19; target implies about 63% upside from $11.62.

Key facts

  1. 01

    Target: $19

  2. 02

    Posted price: $11.62

  3. 03

    Analyst firm: B.Riley Financial

  4. 04

    Analyst: Madison El-Saadi

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.